BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15713130)

  • 1. ABO incompatibility due to immunoglobulin G anti-B antibodies presenting with severe fetal anaemia.
    Ziprin JH; Payne E; Hamidi L; Roberts I; Regan F
    Transfus Med; 2005 Feb; 15(1):57-60. PubMed ID: 15713130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABO haemolytic disease of the fetus and newborn in a blood group AB neonate due to maternal immunoglobulin G anti-A and anti-B antibodies.
    Bu X; Sun P; Wan Y
    Br J Haematol; 2021 Feb; 192(3):416. PubMed ID: 33222150
    [No Abstract]   [Full Text] [Related]  

  • 3. ABO incompatibility and glucose-6-phosphate dehydrogenase deficiency presenting as Hydrops Foetalis.
    Suria AA; Nurasyikin Y; Adibah AG; Cheah FC; Leong CF
    Clin Ter; 2014; 165(3):151-4. PubMed ID: 24999569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence, laboratory diagnosis and serologic prediction of hemolytic disease of newborn infants due to ABO incompatibility].
    Schönitzer D; Frisch H
    Padiatr Padol; 1984; 19(3):263-78. PubMed ID: 6472867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe fetal hydrops resulting from ABO incompatibility.
    Sherer DM; Abramowicz JS; Ryan RM; Sheils LA; Blumberg N; Woods JR
    Obstet Gynecol; 1991 Nov; 78(5 Pt 2):897-9. PubMed ID: 1923220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemolytic disease of fetus and newborn caused by ABO antibodies in a cisAB offspring.
    Deng ZH; Seltsam A; Ye YW; Yu Q; Li Q; Su YQ; Liang YL; Zang H
    Transfus Apher Sci; 2008 Oct; 39(2):123-8. PubMed ID: 18793871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature.
    Yasuda H; Ohto H; Nollet KE; Kawabata K; Saito S; Yagi Y; Negishi Y; Ishida A
    Transfus Med Rev; 2014 Jan; 28(1):1-6. PubMed ID: 24262303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
    Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
    Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
    Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
    Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascular Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immunologic Protein Adsorption.
    Wu Y; Wu Y; Yang Y; Chen B; Li J; Guo G; Xiong F
    Front Immunol; 2021; 12():698541. PubMed ID: 35003054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of the severity of ABO haemolytic disease of the newborn by cord blood tests.
    Whyte J; Graham H
    Acta Paediatr Scand; 1981 Mar; 70(2):217-22. PubMed ID: 7195139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of newborn hemolytic disease with ABO antibodies in sera of pregnant women].
    Yang SM; Wu QY; Luo HQ; Lan JC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):875-7. PubMed ID: 16277862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe hemolytic disease of the newborn in a group B African-American infant delivered by a group O mother.
    Drabik-Clary K; Reddy VV; Benjamin WH; Boctor FN
    Ann Clin Lab Sci; 2006; 36(2):205-7. PubMed ID: 16682519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABO-haemolytic disease of the newborn (ABO-HDN): factors influencing its severity and incidence in Venezuela.
    Cariani L; Romano EL; Martínez N; Montaño R; Suarez G; Ruiz I; Soyano A
    J Trop Pediatr; 1995 Feb; 41(1):14-21. PubMed ID: 7723123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of severity of neonatal hyperbilirubinaemia in ABO incompatibility in Nigeria.
    Owa JA; Durosinmi MA; Alabi AO
    Trop Doct; 1991 Jan; 21(1):19-22. PubMed ID: 1998214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neonatal jaundice with ABO incompatibility. Frequency, treatment and immediate results. Evaluation of over 10,000 newborn infants].
    Crosato M; Benso L; Bogetti G
    Minerva Pediatr; 1970 Jul; 22(28):1409-11. PubMed ID: 5515764
    [No Abstract]   [Full Text] [Related]  

  • 17. Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility.
    Chen JY; Ling UP
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jan; 53(1):13-8. PubMed ID: 8173995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal IgG anti-A and anti-B titres predict outcome in ABO-incompatibility in the neonate.
    Bakkeheim E; Bergerud U; Schmidt-Melbye AC; Akkök CA; Liestøl K; Fugelseth D; Lindemann R
    Acta Paediatr; 2009 Dec; 98(12):1896-901. PubMed ID: 19703120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of high risk pregnancies with relation to ABO haemolytic disease of newborn.
    Usha KK; Sulochana PV
    Indian J Pediatr; 1998; 65(6):863-5. PubMed ID: 10773951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased incidence of haemolytic disease of the new-born caused by ABO-incompatibility when tetanus toxoid is given during pregnancey.
    Gupte SC; Bhatia HM
    Vox Sang; 1980; 38(1):22-8. PubMed ID: 7376563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.